COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

被引:3
|
作者
Declercq, Jozefien [1 ,2 ,3 ]
Tobback, Els [4 ]
Vanhee, Stijn [2 ,3 ]
De Ruyck, Natalie [1 ]
Gerlo, Sarah [5 ,6 ]
Gevaert, Philippe [1 ]
Vandekerckhove, Linos [3 ,4 ,5 ]
机构
[1] Univ Ghent, Upper Airways Res Lab URL, Dept Otorhinolaryngol, C Heymanslaan 10,1P1, Ghent, Belgium
[2] VIB Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium
[3] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium
[4] Ghent Univ Hosp, Dept Gen Internal Med, Ghent, Belgium
[5] Univ Ghent, Dept Internal Med & Pediat, HIV Cure Res Ctr, Ghent, Belgium
[6] Univ Ghent, Dept Biomol Med, Ghent, Belgium
关键词
D O I
10.1111/all.15101
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:304 / 307
页数:4
相关论文
共 50 条
  • [1] Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
    Jie Wei
    Weiya Zhang
    Michael Doherty
    Zachary S. Wallace
    Jeffrey A. Sparks
    Na Lu
    Xiaoxiao Li
    Chao Zeng
    Guanghua Lei
    Yuqing Zhang
    BMC Medicine, 21
  • [2] Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
    Wei, Jie
    Zhang, Weiya
    Doherty, Michael
    Wallace, Zachary S.
    Sparks, Jeffrey A.
    Lu, Na
    Li, Xiaoxiao
    Zeng, Chao
    Lei, Guanghua
    Zhang, Yuqing
    BMC MEDICINE, 2023, 21 (01)
  • [3] BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes
    Abdul-Jawad, Sultan
    Beatson, Richard
    Lechmere, Thomas
    Graham, Rosalind
    Alaguthurai, Thanussuyah
    Graham, Carl
    Vidler, Jennifer
    Kulasekararaj, Austin
    Patten, Piers E. M.
    Doores, Katie J.
    Irshad, Sheeba
    HAEMATOLOGICA, 2022, 107 (05) : 1181 - 1184
  • [4] Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50
    Junqing Xie
    Shuo Feng
    Xintong Li
    Ester Gea-Mallorquí
    Albert Prats-Uribe
    Dani Prieto-Alhambra
    Nature Communications, 13
  • [5] Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50
    Xie, Junqing
    Feng, Shuo
    Li, Xintong
    Gea-Mallorqui, Ester
    Prats-Uribe, Albert
    Prieto-Alhambra, Dani
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [6] Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies
    Radhwi, Osman O.
    Jan, Hamza
    Waheeb, Abdullah
    Alamri, Sawsan S.
    Alahwal, Hatem M.
    Denetiu, Iuliana
    Almanzlawey, Ashgan
    Al-Marzouki, Adel F.
    Almohammadi, Abdullah T.
    Bahashwan, Salem M.
    Barefah, Ahmed S.
    Qari, Mohamad H.
    Abuzenadah, Adel M.
    Hashem, Anwar M.
    VACCINES, 2022, 10 (02)
  • [8] Immunogenicity and efficacy of          heterologous ChAdOx1–BNT162b2 vaccination
    Bruno Pozzetto
    Vincent Legros
    Sophia Djebali
    Véronique Barateau
    Nicolas Guibert
    Marine Villard
    Loïc Peyrot
    Omran Allatif
    Jean-Baptiste Fassier
    Amélie Massardier-Pilonchéry
    Karen Brengel-Pesce
    Melyssa Yaugel-Novoa
    Solène Denolly
    Bertrand Boson
    Thomas Bourlet
    Antonin Bal
    Martine Valette
    Thibault Andrieu
    Bruno Lina
    François-Loïc Cosset
    Stéphane Paul
    Thierry Defrance
    Jacqueline Marvel
    Thierry Walzer
    Sophie Trouillet-Assant
    Nature, 2021, 600 : 701 - 706
  • [9] Comparison of Antibody Response Elicited by ChAdOx1 and BNT162b2 COVID-19 Vaccine
    Kang, Yu Min
    Minn, Dohsik
    Lim, Jaegyun
    Lee, Ki-Deok
    Jo, Dong Ho
    Choe, Kang-Won
    Kim, Moon Jung
    Kim, Jong Min
    Kim, Kwang Nam
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (46)
  • [10] Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19
    Kim, Dong-In
    Lee, Seo Jin
    Park, Soonju
    Kim, Paul
    Lee, Sun Min
    Lee, Nakyung
    Shum, David
    Kim, Dong Ho
    Kim, Eui Ho
    VACCINES, 2022, 10 (11)